Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Assessing if DHA supplementation can amplify the Reelin/Dab-1 pathway to mitigate depression-like symptoms in mice
FY 2023-24
Summary
Studies have found that peripheral injections of Reelin, an endogenous glycoprotein, have fast acting anti-depressant effects in mice. These anti-depressant effects are in-part caused by activation of the Reelin/Disabled-1 (Dab-1) signalling pathway. This proposed study aims to assess if the Reelin/Dab-1 pathway can be amplified by diet to mitigate depression-like symptoms. This is based on previous findings that Reelin signalling can be blunted by diet. Mice fed a high-fat diet showed reduced mIPSC amplitude in hypothalamic neurons after Reelin stimulation, resulting in impaired Reelin signalling. Conversely, docosahexaenoic acid (DHA) can enhance mouse hippocampal synaptic transmission and has anti-depressant properties. Yet, there is limited research investigating the correlation between DHA intake and amplification of the Reelin/Dab-1 signalling pathway. This proposed study will assess if DHA supplementation can increase hippocampal mIPSC following Reelin stimulation and assess if this amplification mitigates depression-like symptoms. First, a forced swim test will assess if DHA supplementation reduces depression-like symptoms. Then, current clamp recordings will measure Reelin-invoked mIPSCs to assess if DHA supplementation increases Reelin signalling. Next, western blots will quantify Dab-1 phosphorylation to assess if the increase in mIPSCs generates an increased signalling response. Lastly, binding assays will determine if DHA supplementation increases the affinity of the Reelin receptor, ApoER2. This may provide an explanation as to how DHA amplifies the Reelin/Dab-1 pathway. If this study finds that DHA amplifies the Reelin/Dab-1 pathway and effectively reduces depressive-like symptoms, then this opens up novel treatment avenues for depression.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506342
Name
Veres Emma L
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Assessing if DHA supplementation can amplify the Reelin/Dab-1 pathway to mitigate depression-like symptoms in mice
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apoer2; Corticosterone; Dab-1; Depression; Docosahexaenoic Acid; Forced Swim Test; Hippocampus; Mice; Mipsc; Reelin
Abstract
Studies have found that peripheral injections of Reelin, an endogenous glycoprotein, have fast acting anti-depressant effects in mice. These anti-depressant effects are in-part caused by activation of the Reelin/Disabled-1 (Dab-1) signalling pathway. This proposed study aims to assess if the Reelin/Dab-1 pathway can be amplified by diet to mitigate depression-like symptoms. This is based on previous findings that Reelin signalling can be blunted by diet. Mice fed a high-fat diet showed reduced mIPSC amplitude in hypothalamic neurons after Reelin stimulation, resulting in impaired Reelin signalling. Conversely, docosahexaenoic acid (DHA) can enhance mouse hippocampal synaptic transmission and has anti-depressant properties. Yet, there is limited research investigating the correlation between DHA intake and amplification of the Reelin/Dab-1 signalling pathway. This proposed study will assess if DHA supplementation can increase hippocampal mIPSC following Reelin stimulation and assess if this amplification mitigates depression-like symptoms. First, a forced swim test will assess if DHA supplementation reduces depression-like symptoms. Then, current clamp recordings will measure Reelin-invoked mIPSCs to assess if DHA supplementation increases Reelin signalling. Next, western blots will quantify Dab-1 phosphorylation to assess if the increase in mIPSCs generates an increased signalling response. Lastly, binding assays will determine if DHA supplementation increases the affinity of the Reelin receptor, ApoER2. This may provide an explanation as to how DHA amplifies the Reelin/Dab-1 pathway. If this study finds that DHA amplifies the Reelin/Dab-1 pathway and effectively reduces depressive-like symptoms, then this opens up novel treatment avenues for depression.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Veres, Emma L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~